Barclays’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Barclays’s Portfolio MSOS Stock Details MSOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.1K	Sell	2,000 -83,005	-98%	-$340K	﹤0.01%	4739
2025 Q4	$401K	Buy	85,005 +60,005	+240%	+$267K	﹤0.01%	3964
2025 Q3	$120K	Hold	25,000	–	–	﹤0.01%	4560
2025 Q2	$60.3K	Sell	25,000 -13,221	-35%	-$32.5K	﹤0.01%	4681
2025 Q1	$99.8K	Hold	38,221	–	–	﹤0.01%	4411
2024 Q4	$146K	Sell	38,221 -4,381	-10%	-$23.6K	﹤0.01%	4464
2024 Q3	$305K	Buy	42,602 +17,521	+70%	+$124K	﹤0.01%	4079
2024 Q2	$184K	Sell	25,081 -6,300	-20%	-$55K	﹤0.01%	3621
2024 Q1	$314K	Buy	31,381 +6,300	+25%	+$55.2K	﹤0.01%	3867
2023 Q4	$176K	Buy	25,081 +81	+0.3%	+$539	﹤0.01%	4473
2023 Q3	$199K	Hold	25,000	–	–	﹤0.01%	3305
2023 Q2	$139K	Hold	25,000	–	–	﹤0.01%	3419
2023 Q1	$142K	Sell	25,000 -2,807	-10%	-$18.6K	﹤0.01%	3984
2022 Q4	$194K	Buy	27,807 +2,300	+9%	+$23.7K	﹤0.01%	3856
2022 Q3	$228K	Sell	25,507 -14,011	-35%	-$162K	﹤0.01%	3129
2022 Q2	$409K	Sell	39,518 -51,906	-57%	-$771K	﹤0.01%	3015
2022 Q1	$1.91M	Buy	+91,424	New	+$1.99M	﹤0.01%	1894

Other funds holding MSOS

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

IECM

Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return

CIA

Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

Barclays's MSOS Position: Q1 2026 in Review

Barclays reduced its AdvisorShares Pure US Cannabis ETF (MSOS) stake by 98% in Q1 2026, selling an estimated $340K and leaving 2,000 shares worth $7.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4739.

Barclays first reported a position in MSOS in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.91M in Q1 2022. 168 funds tracked by Wall St. Rank hold MSOS as of Q1 2026.

Barclays held 2,000 shares of AdvisorShares Pure US Cannabis ETF worth $7.1K as of Q1 2026.
Barclays sold 83,005 AdvisorShares Pure US Cannabis ETF shares in Q1 2026, an estimated $340K.
AdvisorShares Pure US Cannabis ETF made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4739 holding.
Barclays first reported a position in AdvisorShares Pure US Cannabis ETF in Q1 2022 and has held it in 17 quarters since.
Barclays's AdvisorShares Pure US Cannabis ETF position peaked at $1.91M in Q1 2022.
168 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.